高齢者におけるクロザピン：利点と課題

Rachel Moster¹, Sabina Bera¹, Poonam Awatramani²

¹Clinical Psychiatry (RM, SB), Weill Cornell Medicine, New York City, USA.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

|February 28, 2026

まとめ

クロザピンは統合失調症に有効ですが、高齢者は副作用のリスクが高くなります。管理には、他の薬の減量、ライフスタイルの変更、慎重なクロザピン減量が含まれます。

科学分野:

老年精神医学
薬理学

背景:

統合失調症は生活の質と寿命に著しく影響します。
クロザピンは、難治性統合失調症にとって不可欠な治療法です。
長期クロザピンを使用している高齢者は、有害事象のリスク増加のため、慎重な管理が必要です。

研究の目的:

高齢者におけるクロザピン有害事象の管理をレビューすること。
晩年における安全なクロザピン使用のための推奨事項を提供すること。

主な方法:

高齢者におけるクロザピン副作用に関する利用可能な文献のレビュー。
臨床経験に基づく推奨事項。

主要な成果:

高齢者は、肺炎や麻痺性イレウスなどの重篤なクロザピン有害事象の影響を受けやすくなっています。
早期発症の有害事象（無顆粒球症、心筋炎）は、長期使用している高齢者ではまれです。
管理戦略には、多剤併用療法の削減、ライフスタイルの調整、慎重な用量削減が含まれます。

結論:

高齢者におけるクロザピンの管理には、注意深いモニタリングと個別化されたケアが必要です。
治療調整には、患者および家族との共有意思決定が不可欠です。
晩年のクロザピン副作用の管理におけるギャップに対処するため、さらなる研究が必要です。

キーワード:

クロザピン加齢に伴う有害薬物反応長期クロザピン維持療法治療抵抗性統合失調症

さらに関連する動画

07:27

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty

Published on: October 6, 2016

11.0K

10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K

関連する概念動画

01:26

Psychosis: Goals of Pharmacotherapy

642

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

642

01:15

Drug Dosing: Geriatric Patients

328

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

328

01:28

Drug Therapy

333

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

333

01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

287

01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

997

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

997

01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

765

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

765

関連する実験動画